Hector Duarte Jr. - All Headline News Staff Reporter

The company says some patients have been harmed because doctors used its Enteryx injection kit incorrectly

The Food and Drug Administration (FDA) approves a new biologic treatment to treat ulcerative colitis. Manufacturer Centocor, Inc. announces that Remicade has received the green light to treat the chronic inflammatory bowel disease.

Remicade's efficiency in the treatment of inflammatory bowel disease is well established. It was first approved in the United States for the treatment of Crohn's disease in 1998.Remicade remains to this day the only anti-tumor necrosis factor therapy indicated for the treatment of Chron's. With this new approval for the treatment of ulcerative colitis, Remicade is now the only biologic indicated for the treatment of both types of inflammatory bowel diseases

The Food and Drug Administration (FDA) approves a new biologic treatment to treat ulcerative colitis. Manufacturer Centocor, Inc. announces that Remicade has received the green light to treat the chronic inflammatory bowel disease.

Remicade's efficiency in the treatment of inflammatory bowel disease is well established. It was first approved in the United States for the treatment of Crohn's disease in 1998.Remicade remains to this day the only anti-tumor necrosis factor therapy indicated for the treatment of Chron's. With this new approval for the treatment of ulcerative colitis, Remicade is now the only biologic indicated for the treatment of both types of inflammatory bowel diseases

Patients that fail to respond to traditional medications for the treatment of ulcerative colitis, may be able to find success in alternative methods of treatment.

According to new research, consuming a mixture of eight good, or "probiotic," bacteria reduces symptoms in patients with the illness

Wyeth has finally won federal regulatory approval to sell Tygacil. The antibiotic is said to have the ability to fight infections that can't be cured with the treatment with existing medications.

Wyeth says Tygacil cures a wide variety of potentially fatal infections, including those caused by E. coli bacteria. The company also claims Tygacil is indispensable in treating skin infections, ulcers, burns and abscesses